Clinical Trial Management System Market Size, Share, Growth, Trends, Production, Consumption, Revenue and Forecast 2021 to 2028

According to Vision Research Reports, the global clinical trials management system market was valued at US$ 1.7 Bn in 2020 and is anticipated to expand at a CAGR of 10.8% from 2021 to 2028. The global clinical trial management system market size is expected to reach of around US$ 3.6 billion by 2028.

The report provides revenue of the global clinical trials management system market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global clinical trials management system market during the forecast period.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global clinical trials management system market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global clinical trials management system market.

The report delves into the competitive landscape of the global clinical trials management system market. Key players operating in the global clinical trials management system market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global clinical trials management system market that have been profiled in this report.

Overview

• A clinical trial management system (CTMS) is a software solution targeted at the life sciences industry. It is primarily employed to manage the large amount of data involved in a clinical trial including planning, preparation, performance, and reporting. The system emphasizes on keeping up-to-date contact information of participants and tracking deadlines for interim reports and regulatory approvals
• In some cases, CTMS may also provide data to a business intelligence system, which acts as a digital dashboard for trial managers. It provides a user-friendly infrastructure that enables clinicians to manage trials of varying complexity.
• North America dominated the global clinical trial management system market in 2020 and the trend is anticipated to continue during the forecast period, owing to increase in number of clinical trial studies, trend of electronic data management, and emergence of cloud technology.
• Asia Pacific is likely to be a highly lucrative market and it is expected to expand at a high CAGR during the forecast period

Assimilation of Clinical Trial Management Systems (CTMS) with Hospital Information System (HIS) To Drive Market

• Implementation of clinical trial management systems for better work efficiency with HIS is a major driver of the CTMS market. Integration of CTMS with HIS provides more accurate results and saves documentation time as compared to paper-based information systems.
• Some hospitals have their clinical research sections, for example St. Joseph’s Hospital, part of Bay Care Health System, is a leading hospital in the U.S. which conducts clinical trials to study diseases. It uses CTMS for time saving and management of large amount of data involved in clinical trials.
• Likewise, in healthcare and clinical research organizations, CTMS offers a range of services and applications for clinical trial studies. In health care systems, CTMS provide central tracking facilities to various departments during clinical trial studies. Similarly, large amount of data are collected and stored in different HIS, electronic health records, and clinical trial information during clinical trial studies. CTMS captures and organizes the centralized in formation and manages clinical research activities

Cloud-based Clinical Trial Management System Represents the Remarkable Growth

• Based on mode of delivery, the global clinical trial management system market has been divided into cloud-based, on-premise, and web-based.
• The on-remise clinical trial management system segment is poised to account for leading share of the global market in 2020 and is estimated to lose the market share over he forecast period, owing to time-consuming deployment and high cost.
• On the other hand, the cloud-based segment of the clinical trial management system market is anticipated to project by the highest CAGR over the forecast period. Factors attributed to the highest growth of the cloud-based clinical trial management system in the global market include increased productivity, noteworthy reduction of the costs associated to clinical trials and continuous innovations in the product technologies by major market players.

Software is anticipated to be Most Lucrative Segment

• In terms of component, the global clinical trial management system market has been classified into hardware, services, and software.
• The software segment is projected to hold dominant share of global clinical trial management system market in 2020 and is likely to expand at prominent CAGR from 2021 to 2028. Major factors responsible for the dominance of this segment are high sales of software products as compared to hardware, easy customizations, continuous innovations in clinical trial software solutions, and easy deployment of software as compared to hardware.

Enterprise-Based Clinical Trial Management System Is Set to Poise the Highest Growth

• In terms of type, the global clinical trial management system market has been bifurcated into enterprise-based, and site-based.
• Among type, enterprise-based segment of the clinical trial management system market held dominant share of global clinical trial management system market in 2020 and is likely to expand at significant CAGR from 2021 to 2028.
• Growing interest on the application based enterprise solutions, and price discounts by the leading market vendors are the factors anticipated to fuel the growth of the enterprise-based segment over the forecast period. 

Pharmaceutical Industries to Dominate the Global Market

• In terms of end-user, the global clinical trial management system market has been segmented into Pharmaceutical Industries, Contract Research Organizations, Health Care Providers
• A pharmaceutical company performs initial research; conducts clinical trials; and markets drugs. For instance, Merck performs initial research, conducts clinical trials, and markets the drug ‘Keytruda.’
• CTMS solutions are essential for pharmaceutical companies based on this type of research in order to manage complex drug development processes

North America to Dominate Global Market

• In terms of region, the global clinical trial management system market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global clinical trial management system market in 2020, followed by Europe.
• North America is likely to continue its dominance in the global clinical trial management system in 2028, owing to availability of clinical trial management system products, presence of leading product vendors, and highest number of performed clinical trial studies.
• In addition, increasing number of clinical trials in Europe and technological advancements will fuel the growth of the Europe clinical trial management system market.
• The Asia clinical trial management system market is anticipated to project by the highest CAGR over the forecast period, owing to high expenditure of cloud technology, and emergence of contract research organizations in Japan, South Korea and China..

Competitive Landscape

• Key players in the global clinical trial management system market include Oracle, Dassault Système, Parexel International Corporation, IBM, Cinven, Mednet, Microsoft, Apple Inc., Wipro Limited, Bio-Optronics, Inc., Cognizant, DSG, Inc., Forte, Veeva Systems, DATATRAK Int, among others

The global clinical trial management system market has been segmented as follows:

By Mode of Delivery

• • Cloud-based
  • On-premise
  • Web-based

By Component

• • Hardware
  • Services
  • Software

By Type

• • Enterprise-based
  • Site-based

By End-user

• • Pharmaceutical Industries
  • Contract Research Organizations (CRO)
  • Health Care Providers

By Region

• • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific          
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Rest of the World (RoW)

Key Questions Answered in Global Clinical trials management system Market Report

• What is the scope of growth of product companies in the global clinical trials management system market?
• What will be the Y-o-Y growth of the global clinical trials management system market between 2020 and 2027?
• What is the influence of changing trends in technologies on the global clinical trials management system market?
• Will North America continue to be the most profitable market for clinical trials management system providers?
• Which factors are anticipated to hamper the growth of the global clinical trials management system market during the forecast period?
• Which are the leading companies in the global clinical trials management system market?

Research Methodology

A unique research methodology has been utilized by VRR to conduct comprehensive research on the growth of the global clinical trials management system market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary research sources referred to by analysts during the production of the global clinical trials management system market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of VRR’s study on the clinical trials management system market as primary research sources.

These primary and secondary research sources have provided exclusive information during interviews, which serves as a validation from the clinical trials management system market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global clinical trials management system market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching VRR’s estimates on future prospects of the global clinical trials management system market more reliably and accurately.